Tobira Therapeutics
(TBRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 12-2011 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 9,310 |
| Inventories | N/A | 490 |
| Other current assets | 0 | 1,040 |
| TOTAL | $N/A | $10,840 |
| Non-Current Assets | ||
| PPE Net | N/A | 2,280 |
| Other Non-Current Assets | 0 | 3,610 |
| TOTAL | $N/A | $5,890 |
| Total Assets | $N/A | $14,550 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 320 |
| Accrued Expenses | N/A | 1,650 |
| TOTAL | $N/A | $3,250 |
| Non-Current Liabilities | ||
| Long Term Debt | N/A | 4,710 |
| TOTAL | $N/A | $4,710 |
| Total Liabilities | $N/A | $7,970 |
| Shareholders' Equity | ||
| Retained earnings | N/A | -97,470 |
| Other shareholders' equity | 0 | 99,890 |
| TOTAL | $N/A | $6,580 |
| Total Liabilities And Equity | $0 | $14,550 |